STAAR Surgical Company Financials

Market Capitalization $1.18 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	54.43
Forward PE	30.32
Price to Sales TTM	$3.46
Price to Book MRQ	$2.76
Enterprise to Revenue	2.88
Enterprise to EBITDA	29.74

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-29
Most Recent Quarter	2024-09-30
Profit Margin	6.38%
Operating Margin	6.49%
Return on Assets TTM	3.39%
Return on Equity TTM	5.40%

Income Statement

Revenue TTM	$341,224,000
Revenue per Share TTM	$6.96
Quarterly Revenue Growth	10.30%
Gross Profit TTM	$268,659,008
EBITDA	$29,516,000
Net Income to Common TTM	$21,776,000
Diluted EPS TTM	$0.44
Quarterly Earnings Growth YoY	107.20%

Balance Sheet

Total Cash MRQ	$235,958,000
Total Cash per Share MRQ	$4.79
Total Debt MRQ	$
Total Debt to Equity MRQ	9.34
Current Ratio MRQ	5.99
Book Value per Share MRQ	$8.69

Cash Flow

Operating Cash Flow TTM	$47,052,000
Levered Free Cash Flow TTM	$31,717,750

STAA Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	49,275,900
Float Shares	38,046,850
Avg 10 Volume	654,450
Avg 30 Volume	None
Shares Short	3,535,045
Short Ratio	6.03
Short % of Shares	14.30%
% Held by Insiders	0.45%
% Held by Institutions	99.08%

Stock Price Summary

Beta	0.62
Fifty Two Week Low	$21.13
Fifty Two Week High	$52.68
Fifty Two Week Change	-25.56%
Day 50 MA	$25.36
Day 200 MA	$35.43

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	1992-05-18